ATE430805T1 - Modulation der polypeptidexpression auf modifizierten filamentösen phagen - Google Patents

Modulation der polypeptidexpression auf modifizierten filamentösen phagen

Info

Publication number
ATE430805T1
ATE430805T1 AT99942093T AT99942093T ATE430805T1 AT E430805 T1 ATE430805 T1 AT E430805T1 AT 99942093 T AT99942093 T AT 99942093T AT 99942093 T AT99942093 T AT 99942093T AT E430805 T1 ATE430805 T1 AT E430805T1
Authority
AT
Austria
Prior art keywords
modulation
polypeptide expression
filamentous phages
modified filamentous
phage
Prior art date
Application number
AT99942093T
Other languages
English (en)
Inventor
Angray Kang
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE430805T1 publication Critical patent/ATE430805T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT99942093T 1998-08-12 1999-08-11 Modulation der polypeptidexpression auf modifizierten filamentösen phagen ATE430805T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9632698P 1998-08-12 1998-08-12
US09/198,839 US6190908B1 (en) 1998-08-12 1998-12-24 Modulation of polypeptide display on modified filamentous phage
PCT/US1999/018207 WO2000009715A1 (en) 1998-08-12 1999-08-11 Modulation of polypeptide display on modified filamentous phage

Publications (1)

Publication Number Publication Date
ATE430805T1 true ATE430805T1 (de) 2009-05-15

Family

ID=26791575

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99942093T ATE430805T1 (de) 1998-08-12 1999-08-11 Modulation der polypeptidexpression auf modifizierten filamentösen phagen

Country Status (8)

Country Link
US (3) US6190908B1 (de)
EP (1) EP1127142B1 (de)
JP (1) JP2002522084A (de)
AT (1) ATE430805T1 (de)
AU (1) AU766253B2 (de)
CA (1) CA2336541C (de)
DE (1) DE69940853D1 (de)
WO (1) WO2000009715A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6589730B1 (en) 1997-08-29 2003-07-08 Selective Genetics, Inc. Methods for identifying protein-protein interactions by selective transduction
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
US6723512B2 (en) 1997-08-29 2004-04-20 Selective Genetics Inc. Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors
US20030148263A1 (en) * 1997-08-29 2003-08-07 Selective Genetics, Inc. Methods and compositions using genetic package display
IL135776A0 (en) * 1997-10-24 2001-05-20 Life Technologies Inc Recombinational cloning using nucleic acids having recombination sites
WO1999040434A1 (en) 1998-02-04 1999-08-12 Invitrogen Corporation Microarrays and uses therefor
JP4540846B2 (ja) * 1998-04-30 2010-09-08 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ 所望の生物学的特性を与えるクローンを発現ライブラリーから同定する新規方法
US20020119579A1 (en) * 1998-07-14 2002-08-29 Peter Wagner Arrays devices and methods of use thereof
US6780582B1 (en) * 1998-07-14 2004-08-24 Zyomyx, Inc. Arrays of protein-capture agents and methods of use thereof
US6406921B1 (en) * 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
US20030138973A1 (en) * 1998-07-14 2003-07-24 Peter Wagner Microdevices for screening biomolecules
US6576478B1 (en) * 1998-07-14 2003-06-10 Zyomyx, Inc. Microdevices for high-throughput screening of biomolecules
AU5122499A (en) 1998-07-27 2000-02-21 Genentech Inc. Improved transformation efficiency in phage display through modification of a coat protein
US6190908B1 (en) * 1998-08-12 2001-02-20 The Scripps Research Institute Modulation of polypeptide display on modified filamentous phage
US7803765B2 (en) * 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
EP2230303B1 (de) * 1999-05-05 2013-01-16 Phylogica Limited Isolierung von biologischen Modulatoren aus biodiversen Genfragmentbibliotheken
US7270969B2 (en) * 1999-05-05 2007-09-18 Phylogica Limited Methods of constructing and screening diverse expression libraries
JP2004511753A (ja) * 2000-05-04 2004-04-15 イエール　ユニバーシティー タンパク質活性のスクリーニング用タンパク質チップ
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
WO2002046434A2 (en) * 2000-12-08 2002-06-13 Alexion Pharmaceuticals, Inc. Plasmid vectors
EP1493028A4 (de) * 2001-07-06 2006-06-14 Genentech Inc Im phagen-display präsentierte liganden der pdz-domäne
US7799552B2 (en) 2001-07-20 2010-09-21 California Institute Of Technology Protein and nucleic acid expression systems
AU2003229048A1 (en) * 2002-05-14 2003-12-02 Alexion Pharmaceuticals, Inc. T7 bacteriophage display of fabs
AU2003257109A1 (en) * 2002-08-05 2004-02-23 Invitrogen Corporation Compositions and methods for molecular biology
US20050233473A1 (en) * 2002-08-16 2005-10-20 Zyomyx, Inc. Methods and reagents for surface functionalization
AU2003302470A1 (en) * 2002-11-26 2004-06-18 Dyax Corporation Methods and compositions for controlling valency of phage display
EP1587907B1 (de) * 2003-01-07 2011-03-02 Dyax Corporation Kunitz-domäne-bibliothek
US20040248323A1 (en) * 2003-06-09 2004-12-09 Protometrix, Inc. Methods for conducting assays for enzyme activity on protein microarrays
KR20060069825A (ko) * 2003-08-01 2006-06-22 제넨테크, 인크. 제한된 다양성을 갖는 항체 ｃｄｒ 폴리펩티드 서열
US20050106667A1 (en) * 2003-08-01 2005-05-19 Genentech, Inc Binding polypeptides with restricted diversity sequences
US20050048506A1 (en) * 2003-09-03 2005-03-03 Fredrick Joseph P. Methods for encoding non-biological information on microarrays
US20050049796A1 (en) * 2003-09-03 2005-03-03 Webb Peter G. Methods for encoding non-biological information on microarrays
US7108979B2 (en) * 2003-09-03 2006-09-19 Agilent Technologies, Inc. Methods to detect cross-contamination between samples contacted with a multi-array substrate
ATE469984T1 (de) 2003-12-01 2010-06-15 Life Technologies Corp Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
AU2005250369A1 (en) * 2004-05-18 2005-12-15 Genentech, Inc. M13 virus major coat protein variants for C-terminal and BI-terminal display of a heterologous protein
WO2005119244A1 (en) * 2004-06-03 2005-12-15 Phylogica Limited Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
EP1898701A1 (de) * 2005-06-28 2008-03-19 The Scripps Research Institute Abgabe von wirkstoffproteinen an das zentralnervensystem mit phagenvektoren
EP2465870A1 (de) 2005-11-07 2012-06-20 Genentech, Inc. Bindepolypeptide mit verschiedenartigen und übereinstimmenden hypervariablen VH/VL-Sequenzen
US20070237764A1 (en) * 2005-12-02 2007-10-11 Genentech, Inc. Binding polypeptides with restricted diversity sequences
CA2638912A1 (en) * 2006-02-20 2007-08-30 Phylogica Limited Method of constructing and screening libraries of peptide structures
CA2663545A1 (en) * 2006-09-19 2008-03-27 Phylogica Limited Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof
US8822409B2 (en) * 2007-06-20 2014-09-02 Phylogica Limited Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith
US9249408B2 (en) * 2007-11-02 2016-02-02 The Scripps Research Institute Directed evolution using proteins comprising unnatural amino acids
AU2012245073B2 (en) 2011-04-21 2016-02-11 Garvan Institute Of Medical Research Modified variable domain molecules and methods for producing and using them b
EP3209697A4 (de) 2014-10-23 2018-05-30 La Trobe University Fn14-bindende proteine und verwendungen davon
JP6863897B2 (ja) 2015-01-09 2021-04-21 アダルタ・リミテッド Ｃｘｃｒ４結合分子

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5427908A (en) * 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
IL99552A0 (en) * 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
US5698426A (en) * 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
DE69233750D1 (de) * 1991-04-10 2009-01-02 Scripps Research Inst Bibliotheken heterodimerer Rezeptoren mittels Phagemiden
US6190908B1 (en) * 1998-08-12 2001-02-20 The Scripps Research Institute Modulation of polypeptide display on modified filamentous phage

Also Published As

Publication number Publication date
WO2000009715A9 (en) 2000-06-02
US20020146827A1 (en) 2002-10-10
US6586236B2 (en) 2003-07-01
AU766253B2 (en) 2003-10-09
WO2000009715A1 (en) 2000-02-24
EP1127142B1 (de) 2009-05-06
DE69940853D1 (de) 2009-06-18
CA2336541A1 (en) 2000-02-24
AU5554399A (en) 2000-03-06
EP1127142A1 (de) 2001-08-29
EP1127142A4 (de) 2004-05-26
US6323004B1 (en) 2001-11-27
US6190908B1 (en) 2001-02-20
JP2002522084A (ja) 2002-07-23
CA2336541C (en) 2009-12-22

Similar Documents

Publication Publication Date Title
ATE430805T1 (de) Modulation der polypeptidexpression auf modifizierten filamentösen phagen
DE69723254D1 (de) Protein der ausseren membran von moraxella catarrhalis omp-106, dessen gensequenz und dessen verwendung
DE69716465D1 (de) System zur erhaltung der kontinuität eines datenstromes bei unterbrochenen quellendaten
DE69233408D1 (de) Herstellung von Antikörpern auf Phagenoberflächen ausgehend von Antikörpersegmentbibliotheken.
CL2009002139A1 (es) Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral.
ATE369131T1 (de) Verwendung von agonisten des zentralen cannabinoid-rezeptors cb1
DE69738075D1 (de) Affinitätsreinigung von polypeptiden an einer protein a-matrix
GB9921155D0 (en) Selection system
EA199900162A1 (ru) Ингибиторы клеточной адгезии
DE69431797D1 (de) Verfahren und Stoffe zur Modulation der immunsuppressiven Aktivität und Toxitätvon monoklonalen Antikörpern
DE69629232D1 (de) Verfahren zur Planung der optimalen Abfolge von doppelseitigen oder farbigen Ausdrucken
EP0938571B8 (de) Verfahren zur oligomerisation von peptiden
EA199900325A1 (ru) Форма d дигидрата оланзапина
NO942998D0 (no) Fremgangsmåte for dehydrogenering av et alkan, samt alkan-dehydrogeneringskatalysator
GB9715660D0 (en) Proteins
ATE421584T1 (de) Cpg rezeptor (cpg-r) und darauf bezogene methoden
ES2153671T3 (es) Peptidos neuroactivos.
DE69828015D1 (de) Verarbeitungsanordnung und System zur Aktualisierung von Betriebssteuerungsinformationen unter Verwendung der Verarbeitungsanordnung
NO972716L (no) Modulator av funksjonen til FAS/APO1 reseptorer
FI945665A (fi) Retrovirusvektori, joka kykenee transdusoimaan aldehydidehydrogenaasi-1-geenin ja mainitun vektorin käyttö
ES551797A0 (es) Un procedimiento para producir un material de registro sensible a la presion.
TR199801823T2 (en) B�cek �ld�r�c� kar���mlar.
EA199800089A1 (ru) Газопроницаемый материал
DE69938130D1 (de) Neue peptide
ATE398287T1 (de) Wechselwirkungen der katalytischen untereinheit der proteinphosphatase 1

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties